Virginia Retirement Systems’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Other funds holding APLS
Virginia Retirement Systems's APLS Position: Q2 2026 in Review
Virginia Retirement Systems sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 41,665 shares — an estimated $1.68M sold.
Virginia Retirement Systems first reported a position in APLS in Q4 2021 and held it in 12 quarters. The position peaked at $1.68M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Virginia Retirement Systems reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Virginia Retirement Systems sold 41,665 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
- Virginia Retirement Systems first reported a position in Apellis Pharmaceuticals in Q4 2021 and held it in 12 quarters.
- Virginia Retirement Systems's Apellis Pharmaceuticals position peaked at $1.68M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.